Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03632863
Other study ID # 2018-0069-B
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date October 18, 2018
Est. completion date March 2025

Study information

Verified date October 2023
Source Women's College Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Depression in pregnancy is common, affecting up to 10% of women and represents serious risk to mother and infant. Unfortunately, antidepressant medication, a first-line treatment for depression in pregnancy, also comes with risks, making this a complex decision. Clinical care appears to be insufficient for ensuring that women make decisions that are consistent with their own values and with which they feel satisfied. Patient decision support tools can address such barriers. We have created and piloted with positive results an online patient decision aid (PDA) that has the potential to improve the decision-making process for women regarding antidepressant use in pregnancy in conjunction with clinical care. The overall objective of this study is to conduct a Randomized Controlled Trial (RCT) to assess the efficacy of our PDA for antidepressant use in pregnancy.


Description:

A parallel group randomized controlled trial (RCT) will be conducted. Eligible and consenting women with depression will be randomized in a 1:1 ratio to either online PDA or a control condition comprising an online set of publicly available standard resources. The study will be stratified by preconception vs. pregnant, and by province. The study is based at Women's College Hospital (Toronto) but participants will be recruited from across Canada, as the online intervention does not require any in-person study visits. Participants will be recruited via social media (ex. Facebook, Twitter, mommy/baby blogs) and by provider referrals. Participants will be given a series of online questionnaires with various measures collected at baseline, 4 weeks post-randomization, in each trimester of pregnancy, and at 1, 3, 6 and 12 months postpartum. Participants who are planning pregnancy will enter the longer-term (pregnancy and postpartum) follow-up phase once they become pregnant; those who do not conceive by one year post-randomization will be sent a final set of questionnaires and exit the study. A process evaluation will also be conducted to gain insights around trial conduct, and perspectives on potential for (or barriers to) scale-up. This, along with the planned economic evaluation, will inform clinical and policy decisions around adopting the PDA into real-world practice.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 574
Est. completion date March 2025
Est. primary completion date October 2024
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Women aged = 18 years old; and 2. Diagnosed with major depressive disorder (current or in remission); and 3. Planning conception in the next 12 months or < 30 weeks gestational age; and 4. Deciding whether to start or continue a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI) in pregnancy; and 5. Have moderate-to-high decisional conflict regarding the decision to start or continue an SSRI/SNRI in pregnancy; and 6. Live in Canada Exclusion Criteria: 1. Have had alcohol or substance use disorder in prior 12 months; or 2. Have active suicide ideation or psychosis; or 3. Have past/current major obstetrical or fetal complications; or 4. Are unable to complete relevant study procedures online; or 5. Are unable to complete study procedures in English

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Electronic Patient Decision Aid
The electronic PDA is an interactive website with 3 main sections: Review of depression treatment options (non-pharmacological and pharmacological) along with their respective risks and benefits. Interactive "values clarification" exercises to help women determine which risks and benefits are most important to them. Exercises to help women consider how partners, family, providers and the social context impacts decision-making. A summary of how a woman feels about each option along with risks and benefits is generated which can be provided to treating clinicians for use in follow-up. A printable pdf with standard published information and resources is also included.
Standard Resource Sheet
A control group aims to isolate the PDA's effects from time and clinical care. Controls login to the study website and receive the same printable pdf as in the PDA so that they can access standard publicly available information/resources, even if they will not receive the PDA.

Locations

Country Name City State
Canada Women's College Hospital Toronto Ontario

Sponsors (2)

Lead Sponsor Collaborator
Women's College Hospital Canadian Institutes of Health Research (CIHR)

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Postpartum depression as diagnosed by the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 (SCID-I) The depression module will be used to indicate presence of postpartum depression. 3 months postpartum
Secondary Postpartum depression as diagnosed by the Structured Clinical Interview for DSM-5 (SCID-I) The depression module will be used to indicate presence of postpartum depression. 12 months postpartum
Secondary Maternal knowledge of depression, postpartum depression and antidepressant use during pregnancy True/false knowledge questionnaire. baseline and 4 weeks
Secondary Decisional conflict as measured by the Decisional Conflict Scale (DCS) DCS consists of 16 items each rated 1-5 where scores = 25 represent delayed and ineffective decisions. throughout pregnancy (up to 9 months)
Secondary Maternal depression as measured by the Edinburgh Postnatal Depression Scale (EPDS) EPDS is a 10-item self-report scale. Each item is scored 0-3 with scores >12 being predictive of a diagnosis of depression. throughout pregnancy and up to 1 year postpartum (up to 21 months)
Secondary Maternal anxiety as measured by the Spielberger State-Trait Anxiety Inventory (STAI) STAI is a 40-item self-report scale with good discriminate validity in perinatal populations. Each item is scored 1-4 with scores >48 being predictive of an anxiety disorder diagnosis. throughout pregnancy and up to 1 year postpartum (up to 21 months)
Secondary Maternal quality of life as measured by the 12-item Short Form (SF-12) Health Survey SF-12 is a 12-item survey used to estimate the quality-adjusted life year (QALY) which incorporates both length of life and quality of life into a single measure. The measure includes a physical component summary and a mental component summary score. It is scored 0-100 with higher scores indicating better physical and mental health. throughout pregnancy and up to 1 year postpartum (up to 21 months)
Secondary Study website metrics to inform if patterns of PDA use are predictive of clinical outcomes Data generated by the website to inform how participants interact with the PDA: 1) proportion of participants who login to the PDA; 2) timing from enrollment to first login; 3) total number of PDA logins; 4) number of logins between each study time point; 5) proportion of participants who completed the PDA; 6) timing of enrollment to first completion of PDA; 7) number of logins required prior to first completion of PDA; 8) total number of PDA completions; 9) number of PDA completions between each study time point; 10) mean (SD) number of pages viewed per login; 11) whether or not each page was viewed; 12) whether or not each page was viewed between study time points; 13) whether or not each interactive tag was interacted with; 14) whether each interactive tag was interacted with between study time points throughout pregnancy (up to 9 months)
Secondary Health service utilization 1) direct medical costs; 2) indirect medical costs; 3) productivity loss due to patient and family work absence throughout pregnancy and up to 1 year postpartum (up to 21 months)
Secondary Pregnancy complications and neonatal outcomes Self-reported pregnancy complications and neonatal infant characteristics 1 month postpartum
Secondary Infant Outcomes as measured by the Infant Characteristics Questionnaire (ICQ) ICQ is a 27-item questionnaire with each item scored 1-7. Higher scores indicate higher parental perceptions of difficult infant temperament. 3-12 months after birth
Secondary Child Development as measured by the Ages and Stages Questionnaire (ASQ-3) ASQ-3 is a 30-item instrument that screens for child development from 1 to 60 months. Items are scored as 0, 5 or 10 points. Higher scores indicate that the child is doing well. 3-12 months after birth
Secondary Parenting stress measured by the Parenting Stress Index (PSI) short form The PSI-SF is a 36-item measure consisting of 3 subscales (parental distress, dysfunction in parent-child relations, difficult child). Each item is scored 1-5 with higher scores indicating higher levels of parenting stress. PSI reports subscales separately and also reports a total measure. 1 month postpartum to 1 year postpartum
Secondary Partner relationship outcomes measured by the Dyadic Adjustment Scale (DAS) DAS is a self-report measure of relationship adjustment. An abbreviated version of this scale consisting of only the dyadic consensus subscale will be used. Each item is scored 0-5 with higher scores indicating a higher level of agreement amongst couples. throughout pregnancy and up to 1 year postpartum (up to 21 months)
Secondary Bipolar disorder as diagnosed by the Structured Clinical Interview for DSM-5 (SCID-I) The bipolar disorders module will be used. 3 months and 12 months postpartum
Secondary Schizophrenia and other psychotic disorders as diagnosed by the Structured Clinical Interview for DSM-5 (SCID-I) The schizophrenia and other psychotic disorders module will be used. 3 months and 12 months postpartum
Secondary Anxiety disorders as diagnosed by the Structured Clinical Interview for DSM-5 (SCID-I) The anxiety disorders module will be used. 3 months and 12 months postpartum
Secondary Obsessive-compulsive and related disorders as diagnosed by the Structured Clinical Interview for DSM-5 (SCID-I) The obsessive-compulsive and related disorders module will be used. 3 months and 12 months postpartum
Secondary Feeding and eating disorders as diagnosed by the Structured Clinical Interview for DSM-5 (SCID-I) The feeding and eating disorders module will be used. 3 months and 12 months postpartum
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A